Objectives: Modulation of sputum rheology represents an important therapeutic target in chronic inflammatory lung disease such as cystic fibrosis (CF). The novel alginate oligomer (OligoG) modulates pseudomonal biofilms and increases susceptibility of multi-drug resistant bacteria to antibiotics and has previously been shown to modify rheology of mucin/alginate gels, mucin/DNA gels and sputum from a CF patient. This study tested the ability of OligoG to modify the rheological properties of CF sputum. Methods: The effect of OligoG on the viscoelastic properties of sputum samples from cystic fibrosis patients (n = 23) and in a longitudinal study (10 weeks) was studied using shear and extensional rheology. Samples were subjected to 7 treatment modalities:
